RHEUMATOID ARTHRITIS DRUG News, Sports, Shopping, Travel information

Rheumatoid Arthritis
Looking for Rheumatoid Arthritis? Search over 15,000 sites with one click. Your source for everything under the sun!
www.findstuff.com

European Commission Approval Of New Indication For Roche’s Pegasys ... - Webwire
pegasys is the first and only pegylated interferon to be approved for treatment of up to 72 weeks in treatment-experienced patients roche announced today that the european commission has approved pegasys (peginterferon alfa-2a [40 kd]) plus copegus ...
www.webwire.com

(afx Uk Focus) 2008-12-04 08:38 Update 2-u.s. Fda Seeks More Data On Roche Arthritis Drug
zurich, dec 4 (reuters) - the u.s. food and drug administration (fda) has asked for further non-clinical data on roche holding ag's rheumatoid arthritis drug actemra before it approves the potential blockbuster. the swiss group said on thursday the fda had requested additional animal model data but ordered no further clinical studies, and that the company would submit the required information in ...
www.iii.co.uk

Roche Hit As Fda Seeks More Data On Arthritis Drug
* u.s. regulators ask for more data on actemra
sg.news.yahoo.com

2nd Update: Fda Asks Roche For More Data On Key Drug Actemra - Cnn Money
zurich -(dow jones)- roche holding ag (rhhby) suffered a severe setback thursday for its most promising new drug, actemra, when the u.s. food and drug administration asked for a new animal trial and other information, which will delay its launch by ...
money.cnn.com

Update 3-roche Hit As Fda Seeks More Data On Arthritis Drug - Reuters
zurich, dec 4 (reuters) - u.s. approval for roche holding ag's (rog.vx: quote , profile , research , stock buzz ) actemra has been delayed further after regulators asked for more non-clinical data on the potential blockbuster rheumatoid arthritis ...
www.reuters.com

(afx Uk Focus) 2008-12-04 09:49 Update 3-roche Hit As Fda Seeks More Data On Arthritis Drug
by katie reid
www.iii.co.uk

Roche And Fda Agree On Pathway Towards U.s. Approval Of Actemra(r) (tocilizumab)
roche today announced that the u.s. food and drug administration has provided further guidance on the requirements for the biologics license application for actemra® , the first interleukin-6 receptor-inhibiting monoclonal antibody studied for the treatment of adult patients with moderately to severely active rheumatoid arthritis .
biz.yahoo.com

Fda Asks Roche For More Data On Arthritis Drug Actemra - Marketwatch
, , ) said thursday it had been asked by the u.s. food and drug administration to supply additional data and a risk evaluation plan for its rheumatoid arthritis drug actemra. the basel company said it's performing the requested pre-clinical studies ...
www.marketwatch.com

Update 2-u.s. Fda Seeks More Data On Roche Arthritis Drug - Forbes
zurich, dec 4 (reuters) - the u.s. food and drug administration (fda) has asked for further non-clinical data on roche holding ag's rheumatoid arthritis drug actemra before it approves the potential blockbuster. the swiss group said on thursday the ...
www.forbes.com

Results From The First And Largest Collaborative Study Confirm Role Of Enbrel® In Psoriatic Arthritis
new data presented today at the 'gene to clinic' meeting taking place at the royal college of physicians in london, england, reinforce enbrel's ability to clear skin in patients with psoriatic arthritis, an inflammatory and progressive disease associated with psoriasis.
www.medicalnewstoday.com

Groups Criticize Extra Charges In Medicare Drug Benefit, 'lack Of Transparency' On Website
the national senior citizens law center and 11 other advocacy groups in a letter to cms last week asked medicare to stop marketing private medicare prescription drug benefit plans that require extra fees above a standard copayment for hundreds of brand-name drugs, usa today reports.
www.medicalnewstoday.com

Update 1-roche To Submit Response To Fda On Actemra Q3 2009 - Reuters
zurich, dec 4 (reuters) - roche holding ag (rog.vx: quote , profile , research , stock buzz ) will submit information on its rheumatoid arthritis drug actemra that the u.s. food and drug administration has requested for approval in the third quarter ...
www.reuters.com

Investors Support Danish Arthritis Drug Hope - Biotech Sweden
the biotech company cytoguide has received dkk 14 million from four danish and swedish investors to further develop a treatment for rheumatoid arthritis. the aarhus based cytoguide gets support from the investors novo, østjysk innovation, karolinska ...
biotech.idg.se

Ontario Adds Six Drugs To Coverage
provincial plan will include prescription medications for diabetes, cancer, hypertension, rheumatoid arthritis and psoriasis
www.theglobeandmail.com

Six New Prescriptions Covered By Ont. Drug Plan
ontario is adding six prescription drugs to those covered under the ontario public drug programs, including one used by diabetics.
toronto.ctv.ca

Roche And Fda Agree On Pathway Towards U.s. Approval Of Actemra ... - Webwire
swissmedic today approved actemra for use in rheumatoid arthritis roche today announced that the u.s. food and drug administration (fda) has provided further guidance on the requirements for the biologics license application (bla) for actemra ...
www.webwire.com

Adalimumab In Juvenile Rheumatoid Arthritis - New England Journal Of Medicine
to the editor: lovell et al. (aug. 21 issue) 1 report that adalimumab seems to be effective in the treatment of children with juvenile rheumatoid arthritis. however, interpretation of their results is difficult, given the medication-withdrawal design ...
content.nejm.org

Results From The First And Largest Collaborative Study Confirm Role Of Enbrel(r) In Psoriatic Arthritis
maidenhead, england (ots/prnewswire) - - new data add to the body of evidence that show that enbrel (etanercept) clears skin and can sustain this efficacy ...
www.finanznachrichten.de

Results From The First And Largest Collaborative Study Confirm Role Of Enbrel(r) In Psoriatic Arthritis
maidenhead, england (ots/prnewswire) - - new data add to the body of evidence that show that enbrel (etanercept) clears skin and can sustain this efficacy over time new data presented today at the 'gene to clinic' meeting ...
www.presseportal.de

Roche And Fda Agree On Pathway Towards U.s. Approval Of Actemra(r ... - Pr Newswire
nutley, n.j., dec. 4 /prnewswire/ -- roche today announced that the u.s. food and drug administration (fda) has provided further guidance on the requirements for the biologics license application (bla) for actemra(r) (tocilizumab), the first ...
sev.prnewswire.com